cobaltous chloride has been researched along with Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behar-Cohen, F; Bigot, K; Bordet, T; Fan, Y; Inman, DM; Jaworski, T; Kodati, B; Nsiah, NY; Pappenhagen, N; Picard, E; Youale, J | 1 |
| Chen, H; Cui, Y; Li, J; Shao, B; Wang, H; Xia, Z; Zhou, W; Zhu, L; Zhu, X | 1 |
2 other study(ies) available for cobaltous chloride and Glaucoma
| Article | Year |
|---|---|
Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.
Topics: Animals; Disease Models, Animal; Glaucoma; Hypoxia; Intraocular Pressure; Iron; N-Methylaspartate; Neuroprotective Agents; Ocular Hypertension; Rats; Transferrin | 2022 |
Muscarinic activation attenuates abnormal processing of beta-amyloid precursor protein induced by cobalt chloride-mimetic hypoxia in retinal ganglion cells.
Topics: ADAM Proteins; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Cobalt; Glaucoma; Hypoxia; Muscarinic Agonists; Rats; Receptors, Muscarinic; Retinal Ganglion Cells; RNA, Messenger | 2009 |